To mark the first World Pneumonia Day, Inter Press Service examines how vaccines and other strategies can be used to combat the disease, which kills more children under age 5 each year “than measles, malaria, and AIDS combined, according to the Global Coalition against Child Pneumonia.”
Programs, Funding & Financing
Fistula Hospital Plan Is A Great Investment For American Foreign Aid In a New York Times opinion piece, columnist Nicholas Kristof examines a new plan to tackle obstetric fistula, “a childbirth injury, often suffered by a teenager in Africa or Asia whose pelvis is not fully grown.” According to Kristof,…
To mark the first World Pneumonia Day on Monday, the WHO and UNICEF launched a $39 billion Global Action Plan for Prevention and Control of Pneumonia (GAPP) aimed at preventing 5.3 million child deaths from the disease by 2015, the Associated Press reports (Cheng, 11/1).
JAIDS Supplement Focuses On Global Health Systems “Action always leads to reaction, a fundamental law of nature,” write the authors of an introduction appearing in a Journal of Acquired Immune Deficiency Syndromes (JAIDS) supplemental issue that focuses on global health systems. “Central to the debate [over investments in HIV/AIDS spending]…
A report released Thursday by a group of global health experts outlines ways the U.S. can work toward increasing access to health care throughout the world, Inter Press Service reports.
The New York Times examines the “debate over whether the United States and other rich nations spend too much on AIDS, which requires lifelong medications, compared with diarrhea and the other leading killer of children, pneumonia, both of which can be treated inexpensively.”
Foreign pharmaceutical companies on Wednesday accepted the decision of Ecuador’s President Rafael Correa to enable the country “to bypass patents on 2,000 drugs in order to produce them locally or buy cheaper versions elsewhere,” Agence France-Presse reports.
GlaxoSmithKline CEO Andrew Witty said Wednesday the company would ensure that if an experimental malaria vaccine works, it would be priced reasonably, Reuters reports. “The vaccine, called Mosquirix [or RTS,S] and the first malaria shot to make it to final-stage trials, is creating a buzz ahead of a conference of 1,500 malaria experts in Nairobi next week,” writes Reuters.
Also In Global Health News: Germany HIV/AIDS Grant; Sumatra Water Situation; India’s Unlicensed Doctors; Land Ownership, Food Security
Germany Grants $34M For HIV/AIDS Work In Central Africa The Organisation for the Coordination of the Struggle Against Epidemics in Central Africa (OCEAC) on Tuesday announced that the German government has granted $34 million to help prevent the spread of HIV/AIDS in central Africa, Agence France-Presse reports. “The Germany-backed project…
Gates Foundation Praises U.S. Global Health Investments, Calls For 15-Year Goal Of Cutting Child Deaths Worldwide By Nearly Half
As part of a “major push to convince the United States to maintain government spending on worldwide health initiatives, despite the financial crisis and a soaring U.S. budget deficit,” the Bill & Melinda Gates Foundation is urging U.S. policymakers to commit to cutting “the number of child deaths each year, from 9 million to 5 million” by 2025, CNN reports.